Janumet Tablet, Film Coated
Product Images NDC 50090-5502

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Janumet (NDC 50090-5502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sitagliptin Chemical Structure (Janumet 01)

Chemical structure depiction of the active ingredient sitagliptin, part of the product JANUMET which contains sitagliptin and metformin hydrochloride.*

FDA Label Image

Metformin Hydrochloride Chemical Structure (Janumet 02)

Chemical structure of sitagliptin, shown with the hydrochloride (HCl) component.*

FDA Label Image

Figure 1 (Janumet 03)

Line graph showing least squares mean change from baseline over 24 weeks comparing placebo and various dosing regimens of sitagliptin and metformin. The x-axis represents weeks (0 to 24), and the y-axis shows mean change. Six groups are displayed: placebo, sitagliptin 100 mg once daily, metformin 500 mg twice daily, metformin 1000 mg twice daily, sitagliptin 50 mg twice daily plus metformin 500 mg twice daily, and sitagliptin 50 mg twice daily plus metformin 1000 mg twice daily.*

FDA Label Image

Figure 2 (Janumet 04)

A line graph comparing the least squares (LS) mean change from baseline over 52 weeks between Sitagliptin 100 mg and Glipizide. The x-axis represents weeks (0 to 52) and the y-axis shows the LS mean change from baseline, ranging from 0 to -1.5. Two lines track the changes for Sitagliptin (solid diamonds) and Glipizide (open circles), showing a decrease early on followed by a gradual increase after about week 30.*

FDA Label Image

Label Image (Lbl500905502)

JANUMET 50 mg/1000 mg film-coated tablets packaging label displaying the active ingredients Sitagliptin and Metformin Hydrochloride. The label states each tablet contains 50 mg Sitagliptin and 1000 mg Metformin HCl equivalent to 925 mg Metformin Hydrochloride. It indicates storage instructions between 68 to 77 degrees Fahrenheit and a count of 60 tablets. The product is labeled by A-S Medication Solutions with NDC 50090-5502.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.